Infectious Disease Research Institute
From Wikipedia the free encyclopedia
The Infectious Disease Research Institute (IDRI) was a non-profit organization based in Seattle, in the United States, and which conducts global health research on infectious diseases. Its new name is Access to Advanced Health Institute (AAHI).
History[edit]
IDRI was founded in 1993, by Steve Reed, PhD. [1]
Malaria vaccine[edit]
IDRI is collaborating with the United States Agency for International Development to develop a malaria vaccine with the Walter Reed Army Institute of Research using Walter Reed's CelTOS malaria antigen in conjunction with IDRI's GLA-SE adjuvant.[2]
Visceral leishmaniasis vaccine[edit]
In February 2012, IDRI launched the world's first clinical trial of the visceral leishmaniasis vaccine. The vaccine is a recombinant form of two fused Leishmania parasite proteins with an adjuvant. Two phase 1 clinical trials with healthy volunteers are to be conducted. The first one takes place in Washington and is followed by a trial in India. The trials are funded by the Bill & Melinda Gates Foundation.[3]
References[edit]
- ^ "Home". idri.org. Archived from the original on 2009-03-26. Retrieved 2011-09-12.
- ^ Erica Teichert (18 August 2011). "USAID, IDRI form malaria vax collaboration". fiercevaccines.com. Retrieved 12 September 2011.
- ^ Elvidge, Suzanne (February 23, 2012). "World's first kala azar vaccine enters the clinic". FierceVaccines.com. Retrieved March 1, 2012.
